Vida Ventures LLC 13D and 13G filings for Kyverna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-03 5:57 pm Purchase |
2024-02-12 | 13D | Kyverna Therapeutics, Inc. KYTX |
Vida Ventures LLC | 4,777,060 11.100% |
4,777,060 (New Position) |
Filing |